Speakers
Gabriele Schwarz, MPharm
GCP Strategy Expert, Federal Institute for Drugs and Medical Devices (BfArM), Germany
Gabriele Schwarz, a registered pharmacist, joined the Federal Institute for Drugs and Medical Devices (BfArM) in 2001. She is currently BfArM’s GCP Strategy Expert and represents the EU in the ICH E6(R3) EWG, which is working on a revision of the GCP guideline. She is also contributing to a number of activities of the EMA ACT-EU project. Until the end of 2022, she was Head of BfArM’s GCP Inspectorate. In parallel, she has contributed to the development of a number of European guidelines e.g. for Risk-Based Quality Management, eSource, (e)TMF and Clinical Trials with Decentralised Elements, and also to international guidelines such as the OECD Recommendation on the Governance of Clinical Trials, the ICH E6(R2) and the ICH E19 Guideline.
Beat Widler, PhD
Co-Founder and Vice President, ACRES; Managing Director, Widler & Schiemann AG, Switzerland
+25 years experience in Drug Regulatory Affairs and Clinical Science. DIA Board Director and chair of the Advisory Committee Europe. Managing Partner at Widler & Schiemann Ltd, Zug, Switzerland
Have an account?